NXT.AU

16.47

+1.29%↑

SFR.AU

10.25

-1.54%↓

LLC.AU

6.79

+1.34%↑

BRG.AU

31.97

+2.96%↑

NXT.AU

16.47

+1.29%↑

SFR.AU

10.25

-1.54%↓

LLC.AU

6.79

+1.34%↑

BRG.AU

31.97

+2.96%↑

NXT.AU

16.47

+1.29%↑

SFR.AU

10.25

-1.54%↓

LLC.AU

6.79

+1.34%↑

BRG.AU

31.97

+2.96%↑

NXT.AU

16.47

+1.29%↑

SFR.AU

10.25

-1.54%↓

LLC.AU

6.79

+1.34%↑

BRG.AU

31.97

+2.96%↑

NXT.AU

16.47

+1.29%↑

SFR.AU

10.25

-1.54%↓

LLC.AU

6.79

+1.34%↑

BRG.AU

31.97

+2.96%↑

Kodu・Aktsiate loetelu・Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corp Ltd

Suletud

Sektor Kinnisvara

33.08 0.39

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

32.61

Max

33.09

Põhinäitajad
By Trading Economics
Sissetulek	13M
Müük	470M
Aktsiakasum	0.021
Kasumimarginaal	2.694

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+6.3 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	28. nov 2024
Järgmine dividendimakse kuupäev	16. dets 2024
Järgmine aktsia dividendi kuupäev (ex-date)	3. dets 2024

Turustatistika
By TradingEconomics
Turukapital	47M 21B
Eelmine avamishind	32.69
Eelmine sulgemishind	33.08

Uudiste sentiment

By Acuity

85%

15%

183 / 193 Pingereas Real estate

Fisher & Paykel Healthcare Corp Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. nov 2023, 21:34 UTC

Tulu

Fisher & Paykel Lifts 1st Half Profit 12% Amid Easing Freight Costs

2. sept 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

30. mai 2024, 00:44 UTC

Market Talk

Tulu

Fisher & Paykel FY 2025 Guidance Hinges on Currency -- Market Talk

29. mai 2024, 23:35 UTC

Market Talk

Fisher & Paykel to Benefit From FX Tailwinds -- Market Talk

28. mai 2024, 22:43 UTC

Market Talk

Fisher & Paykel Healthcare Making Progress in Improving Margins -- Market Talk

28. mai 2024, 20:59 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Net Profit After Tax NZ$310M to NZ$360M

28. mai 2024, 20:58 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. Sees FY25 Rev NZD1.9B-NZD2B

28. mai 2024, 20:57 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. FY24 Net Profit After Tax NZ$132.6M

28. mai 2024, 20:56 UTC

Tulu

Fisher & Paykel Healthcare Corp. Ltd. FY24 Rev NZD1.742B

24. apr 2024, 02:38 UTC

Market Talk

F&P Healthcare's Prospects Brighten on Anaesthesia Opportunity -- Market Talk

25. märts 2024, 22:04 UTC

Market Talk

F&P Healthcare Can Meet Market Expectations for Revenue Growth -- Market Talk

29. nov 2023, 02:47 UTC

Market Talk

Fisher & Paykel's Profit Guidance Looks Strong -- Market Talk

28. nov 2023, 21:19 UTC

Tulu

Fisher & Paykel Lifts 1H Profit 12% Amid Easing Freight Costs

28. nov 2023, 00:11 UTC

Market Talk

Fisher & Paykel's 2H Trends Key for Macquarie Analysts -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Fisher & Paykel Healthcare Corp Ltd Prognoos

Hinnasiht

By TipRanks

6.3% tõus

12 kuu keskmine prognoos

Keskmine 35.047 AUD 6.3%

Kõrge 35.1 AUD

Madal 35 AUD

Põhineb 5 Wall Streeti analüütiku instrumendi Fisher & Paykel Healthcare Corp Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Fisher & Paykel Healthcare Corp Ltd aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

183 / 193 Pingereas Kinnisvara

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.